Drugs :: Amgen to participate in Oncologic Drugs Advisory Committee in May
Amgen (NASDAQ: AMGN) announced that the U.S. Food and Drug Administration (FDA) has invited the Company to participate at an upcoming meeting of the Oncologic Drugs Advisory Committee (ODAC).